The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis

Overview of attention for article published in Frontiers in Pharmacology, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 2 citations on 2 Wikipedia pages.

Lianhua Qingwen (连花清瘟, LHQW) is a traditional Chinese medicine (TCM) formulation used for the treatment of influenza.

连花清瘟，按剂型称为连花清瘟胶囊、连花清瘟颗粒，是治疗SARS期间研究的一种中成药。该药的主要成份为连翘、金银花、炙麻黄、炒苦杏仁、石膏、板蓝根、棉马贯众、鱼腥草、广藿香、大黄、红景天、薄荷脑、甘草。以岭药业拥有此药的诸多发明专利和用途专利，2011年其制造工艺获国家科技进步二等奖。.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.